Decision Support
Compare Products
Side-by-side comparison of 2–3 reviewed products. Empty cells mean the manufacturer has not published that value — we show what sources support, nothing more.
Filled with competing tests for the same target from other manufacturers, where the catalogue has them — swap any column with the picker above.
| Field | AVENIO Tumor Tissue Surveillance Kit V2 | Seraseq Tri-Level Tumor Mutation DNA Mix v2 HC | ExaccType ESR1 dPCR Kit |
|---|---|---|---|
| Manufacturer | Roche Diagnostics | LGC SeraCare Life Sciences | Biotype GmbH |
| Category | Sequencing & Genomics | Sequencing & Genomics | Molecular Assays |
| Technology | Next-Generation Sequencing | Next-Generation Sequencing | Digital PCR |
| Regulatory status | RUO | RUO | Not disclosed |
| Verified | 2026-10-27 | 2026-10-17 | 2026-10-28 |
| Linked registration records | 0 record(s) | 0 record(s) | 0 record(s) |
| Source | Official page | Official page | Official page |
| Next step | Request quote | Request quote | Request quote |
Comparisons use manufacturer-published specifications and our editorial review; registration claims are counted from linked regulatory records only.